New Involvement

Written By ExoMira Medicine

CHICAGO, IL; April 2023: ExoMira co-founder Dr. Huiping Liu, Associate Professor of Pharmacology and Medicine (Hematology/Oncology) at Northwestern University was inducted as an elected member to American Society for Clinical Investigation (ASCI).

ExoMira Medicine

ExoMira Medicine Inc. (“ExoMira”) is a Chicago-based preclinical-stage pharmaceutical company (a spin-off from Northwestern University) focused on developing innovative cancer immunotherapies.

Previous

New Publication
Next

New Ecosystem